Regulus Therapeutics Inc. (RGLS)

NASDAQ: RGLS · Real-Time Price · USD

7.85

-0.13 (-1.63%)

At close: May 01, 2025, 3:59 PM

7.83

-0.25%

After-hours: May 01, 2025, 07:58 PM EDT

Regulus Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	10.01M	6.83M	72K	72K	1.19M
Cost of Revenue	n/a	21.15M	122K	459K	15.35K	12.35K	33.98M	54.59M	64.31M
Gross Profit	n/a	-21.15M	-122K	-459K	9.99M	6.82M	-33.9M	-54.52M	-63.11M
Operating Income	-50.04M	-31.11M	-28.24M	-27.82M	-14.15M	-16.83M	-46.76M	-70.13M	-81.5M
Interest Income	3.84M	1.68M	605K	864K	233K	374K	459K	752K	844K
Pretax Income	-46.36M	-30.04M	-28.32M	-27.81M	-15.73M	-18.59M	-48.65M	-72.1M	-81.84M
Net Income	-46.36M	-30.04M	-28.32M	-27.81M	-15.26M	-18.59M	-48.71M	-71.91M	-81.84M
Selling & General & Admin	14.67M	9.96M	9.83M	10.02M	8.81M	11.32M	12.86M	17.01M	18.39M
Research & Development	35.37M	21.01M	18.41M	17.79M	15.35M	12.35M	33.98M	53.19M	64.31M
Other Expenses	n/a	-21.01M	-83K	9K	-1.57M	-1.76M	-1.88M	n/a	n/a
Operating Expenses	50.04M	9.96M	28.24M	27.82M	24.16M	23.67M	46.84M	70.2M	82.7M
Interest Expense	158K	604K	688K	855K	1.81M	2.13M	2.34M	2.72M	1.18M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	50.04M	31.11M	28.24M	27.82M	24.16M	23.67M	46.84M	70.2M	82.7M
Income Tax Expense	1K	1K	1K	1K	-467K	1K	62K	-197K	-4K
Shares Outstanding (Basic)	56.35M	18.96M	15.26M	8.57M	3.5M	1.73M	871.86K	626.92K	440.11K
Shares Outstanding (Diluted)	56.35M	18.96M	15.26M	8.57M	3.5M	1.73M	871.86K	626.92K	440.11K
EPS (Basic)	-0.82	-1.58	-1.86	-3.24	-4.36	-10.77	-55.87	-114.7	-185.94
EPS (Diluted)	-0.82	-1.58	-1.86	-3.24	-4.36	-10.77	-55.87	-114.7	-185.94
EBITDA	-45.85M	-30.88M	-28.12M	-27.36M	-13.46M	-15.53M	-44.04M	-66.86M	-78.38M
EBIT	-46.2M	-31.11M	-28.24M	-27.82M	-13.92M	-16.46M	-46.3M	-69.38M	-80.66M
Depreciation & Amortization	347K	227K	122K	459K	467K	931K	2.26M	2.52M	2.28M